Federal Reserve Economic Data: Your trusted data source since 1991

Quarterly

F.130 Security Brokers and Dealers

   

Please select a date range

    Q4 1946    
 
 
    Q4 2023
Millions of Dollars
Line Name Period Value Preceding
Period
Year Ago
from Period
line 1
Gross saving less net capital transfers paid
Q4 2023 21,020 20,440 18,261
line 2
Fixed nonresidential investment
Q4 2023 61,112 60,095 57,620
line 3
Net acquisition of financial assets
Q4 2023 472,746 -274,037 -309,873
line 4
Checkable deposits and currency
Q4 2023 -7,216 -26,532 -17,432
line 5
Security repurchase agreements
Q4 2023 86,396 -134,876 524,024
line 6
Debt securities
Q4 2023 -164,088 249,200 131,350
line 7
Open market paper
Q4 2023 -20,348 -17,008 -17,600
line 8
Treasury securities
Q4 2023 -102,296 78,516 50,286
line 9
Agency- and GSE-backed securities
Q4 2023 -11,760 140,712 160,564
line 10
Municipal securities
Q4 2023 -10,400 912 -12,916
line 11
Corporate and foreign bonds
Q4 2023 -19,284 46,068 -48,984
line 12
Loans (other loans and advances)
Q4 2023 64,092 -12,116 -581,392
line 13
Corporate equities
Q4 2023 11,100 -58,568 -139,268
line 14
U.S. direct investment abroad
Q4 2023 0 0 0
line 15
Miscellaneous assets
Q4 2023 482,461 -291,146 -227,155
line 16
Net increase in liabilities
Q4 2023 471,698 -284,445 -348,965
line 17
Security repurchase agreements
Q4 2023 170,932 51,396 50,660
line 18
Debt securities (corporate bonds)
Q4 2023 60,856 39,356 50,020
line 19
Loans
Q4 2023 101,744 -205,248 -256,360
line 20
Depository institution loans n.e.c.
Q4 2023 37,268 38,776 11,420
line 21
Other loans and advances
Q4 2023 108,748 -260,496 -216,976
line 22
Corporate equity issues
Q4 2023 30,764 17,020 -2,708
line 23
Trade payables
Q4 2023 -11,936 -5,436 1,768
line 24
Taxes payable
. . . .
line 25
Foreign direct investment in U.S.
Q4 2023 94,808 -33,680 57,420
line 26
Miscellaneous liabilities
Q4 2023 154,806 -163,821 -185,733
line 27
Investment by parent companies
. . . .
line 28
Other
Q4 2023 -82,324 -320,333 -7,681
line 29
Proprietors' net investment
. . . .
line 30
Discrepancy
Q4 2023 -91,579 68,821 -124,551
   

Subscribe to the FRED newsletter


Follow us

Back to Top